Future Rare Diseases is a peer-reviewed, open access journal that aims to provide a resource for all those working in the field, including scientists, clinicians, policy makers and patient advocates. The journal enables the sharing of knowledge and increased exposure to the vital work being carried out in the rare disease area, including regarding disease diagnosis and the development of treatments. Content published in Future Rare Diseases covers all rare and ultra-rare diseases.
This first issue of the journal represents the wide range of article types that can be published in Future Rare Diseases and the impact of the latest research in raising awareness for rare diseases.
The Interview with Christian Rubio (Global Genes, CA, USA) discusses the work Global Genes is undertaking to improve the lives of patients and caregivers living with a rare disease. A Commentary article focuses on the potential of technology to improve healthcare in rare diseases and how this may develop over the coming years. A Perspective article serves as the steps of reclassifying ‘negative’ clinical trials in rare diseases into five categories, which aim to better reflect the trial characteristics and be more useful to all stakeholders, especially patients and healthcare providers.
The issue’s Research Article investigates the prevalence of Dercum’s disease, a rare loose connective tissue disorder characterized by painful lipomas or angiolipomas. Finally, the last article in this issue, a meta-analysis, evaluates the efficacy and safety of transfusing leukoreduced red blood cells and/or washed red blood cells in the treatment of autoimmune hemolytic anemia.
In Future Rare Diseases we hope to increase awareness, treatment options and knowledge of rare diseases by publishing peer-reviewed, open access research and opinion. The first issue is available to view online here.